Tirzepatide Resolves MASH Without Worsening Fibrosis
Tirzepatide, a novel therapeutic agent, has emerged as a beacon of hope for individuals grappling with metabolic dysfunction-associated steatohepatitis (MASH). Recent findings have illuminated promising...
















